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Abstract 
Study question: Does diet, physical activity and contraceptive use change after receiving a 
diagnosis of polycystic ovary syndrome (PCOS)? 
Summary answer: Using longitudinal data 12 months apart, young women newly diagnosed 
with PCOS were more likely to stop using contraception but did not change their physical 
activity or vegetable intake.  
What is known already: Diagnostic criteria for PCOS have widened to capture more women, 
despite limited evidence of the benefits and harms. Possible benefits of a PCOS diagnosis 
are that it may help women with family planning and motivate them to implement healthy 
lifestyle changes to reduce the reproductive, metabolic and cardiovascular risks associated 
with PCOS. However, there are no empirical studies investigating how women respond to a 
diagnosis of PCOS with respect to their health behaviour, and longitudinal population-based 
studies are lacking. 
Study design, size, duration: This is a longitudinal analysis of two waves of data collected 12 
months apart from the cohort born 1989-1995 in the Australian Longitudinal Survey on 
Women’s Health, a population-based cohort study.  
Participants/ materials, setting, methods: Women who responded to the 2014 survey 
(aged 19-24, n=11,344) and 2015 survey (aged 20-25, n=8,961) were included. Using logistic 
regression, multinomial logistic regression and linear regression, change in vegetable intake, 
physical activity and contraceptive use were compared for women newly diagnosed with 
PCOS to women not reporting a diagnosis of PCOS. Changes in psychological distress and 
BMI were also examined. 
Main results and the role of chance: Young women reporting a new diagnosis of PCOS were 
no more likely to increase their vegetable intake or physical activity than women not 
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reporting a PCOS diagnosis. Women newly diagnosed with PCOS were 3.4 times more likely 
to stop using contraception during the 12-month study period than women without PCOS 
(14% vs 4%, 95% CI=2.3 to 5.1, p<0.001). This difference remained significant after 
controlling for demographics, chronic conditions associated with PCOS, endometriosis, body 
mass index and psychological distress (p<0.001). 
Limitations, reasons for caution: All data was self-reported including PCOS diagnosis, 
assessment of diet quality was limited to vegetable intake only and exact timing of diagnosis 
within the 12-month period is unknown. 
Wider implications of the findings: These findings suggest that a diagnosis of PCOS may not 
produce short-term benefits by way of improving health behaviour. The observed reduction 
in contraception use suggests some women may be at increased risk of unplanned 
pregnancies, highlighting the importance of counselling about contraceptive needs. Both 
potential benefits and harms must be considered when determining the appropriateness of 
a PCOS diagnosis. 
Study funding/ competing interest(s): The Australian Longitudinal Study on Women’s 
Health is funded by the Australian Government Department of Health. BWM reports 
consultancy for ObsEva, Merck, Merck KGaA and Guerbet. No further competing interests 
exist. 
Trial registration number: N/A 
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Introduction 
Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in reproductive-
aged women, and is associated with adverse reproductive, metabolic and psychological 
outcomes (Dumesic et al., 2015). The Rotterdam diagnostic criteria (2003) expanded the 
initial National Institute of Health criteria for PCOS (1991) by including polycystic ovarian 
morphology (The Rotterdam ESHRE/ASRM PCOS Workshop, 2004), including women with 
milder phenotypes and increasing the number of women diagnosed (Skiba et al., 2018). This 
expansion aroused considerable debate, as polycystic ovaries using the 2003 Rotterdam 
definition are also commonly found in women without PCOS (Duijkers & Klipping, 2010; 
Lauritsen et al., 2014), raising concerns about overdiagnosis (Copp et al., 2017). The 
rationale for the expanded criteria was to capture the broad clinical expression of PCOS 
(Dumesic et al., 2015). It is posited that knowledge of a PCOS diagnosis might motivate 
women to engage in recommended lifestyle changes (Banting et al., 2014), reducing the 
potential risks of long-term consequences, such as insulin resistance, obesity and type II 
diabetes (Cooney & Dokras, 2018; Gibson-Helm et al., 2017). Additionally, a diagnosis of 
PCOS may improve access to treatment, such as the oral contraceptive pill to help manage 
hormonal symptoms (e.g. irregular menstruation, acne, hirsutism) and reduce the risk of 
endometrial carcinoma (Teede et al., 2018). However, the criteria have expanded despite a 
lack of clear evidence of meaningful benefits in terms of reduced risk of adverse outcomes 
for those newly diagnosed. Additionally, neither the potential benefits nor harms of this 
expanded definition have been rigorously investigated (Copp et al., 2017). 
 
Whether a PCOS diagnosis actually results in healthier behaviour remains unclear. The 
limited research available suggests that a PCOS diagnosis could positively impact diet but 
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also negatively impact perceived weight control and potentially even lead to disordered 
eating (Lin et al., 2018; Moran et al., 2017). A cross-sectional study of women aged 31-36 
years in the community found that women with PCOS were more likely to use both healthy 
(e.g. reducing meal size, fat or sugar intake) and maladaptive (e.g. use of laxatives, fasting or 
diuretics) weight loss methods than women without PCOS (Moran et al., 2017). Studies 
examining weight-related beliefs have also found that women with PCOS are aware they are 
at higher risk of obesity and associated diseases (Lin et al., 2018; Moran et al., 2010), but 
perceive poorer control over their weight and fewer benefits of healthy behaviours on 
weight gain compared to women without PCOS (Lin et al., 2018). Conversely, studies in 
other conditions suggest that communicating personalised risk information or giving a 
chronic disease diagnosis has no impact on health-related behaviour (Dontje et al., 2016; 
French et al., 2017). Longitudinal research is needed to examine the impact of a PCOS 
diagnosis on health behaviour.   
 
Despite hormonal contraceptives being first-line treatment for regulating hormonal aspects 
associated with PCOS (Legro et al., 2013; Teede et al., 2018), previous cross-sectional 
studies of women aged 18-23 and aged 28-33 have found that women with PCOS are less 
likely to report using contraception than their peers (Joham et al., 2014; Rowlands et al., 
2016). However, the extent to which this is due to diagnosis of the condition is unclear, as 
contraceptive use prior to diagnosis was not assessed. Further investigation of change in 
contraceptive use after a diagnosis of PCOS is warranted.  
 
Given the limited knowledge of the impact of a PCOS diagnosis on health behaviour, the 
purpose of this study was to examine whether there were significant changes in young 
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women’s behaviour after receiving a diagnosis of PCOS, compared to women without PCOS. 
This paper uses a national, longitudinal cohort study of young Australian women to examine 
changes in vegetable intake, physical activity and contraceptive use over a 12-month period 
comparing women newly diagnosed with PCOS to women without PCOS. Changes in body 
mass index (BMI) and psychological distress were also examined as secondary outcomes.  
 
Materials and methods 
Study design 
Data used in this study are from participants in the cohort born in 1989-1995 of the 
Australian Longitudinal Study on Women’s Health (ALSWH), a prospective study about 
women’s health and wellbeing. Participants were recruited through conventional 
advertising and online social media platforms (Mishra et al., 2014). Eligible women were 
living in Australia, held a valid Medicare number, and consented to data linkage with 
administrative health data. Women received the first web-based survey in 2012-2013, with 




The study was approved by the Ethics Committees of the Universities of Newcastle and 
Queensland, as well as the Australian Department of Health and the Australian Department 
of Human Services. Informed consent was implied by completion of the survey. To obtain 
access to the data, a detailed application form outlining the study’s rationale, research 
questions and analysis plan was submitted to and approved by the ALSWH data access 
committee.  




A total of 17,015 young women completed the baseline survey (first wave) in 2012-2013 
when they were aged 18-23 years (see Figure 1). In the current study, data from women 
who responded to both the second wave in 2014 (aged 19-24) and third wave in 2015 (aged 
20-25) were used. Vegetable intake was not measured at baseline, so the first wave was not 
used in the current study. For clarity, the second wave and third wave will herein be 
referred to as Time 1 (T1) and Time 2 (T2). As our research question focused on those with a 
new diagnosis of PCOS (at T2), participants who reported a diagnosis of PCOS at T2 but not 
T1 were included in the analysis, along with women not reporting PCOS at either time point. 
Thus, our analysis included data from 7,170 participants.  
 
Measures 
Diagnosis of PCOS  
Participants were asked “Have you ever been diagnosed or treated for polycystic ovary 
syndrome?” at T1 and T2. A transition variable for PCOS status was created, with responses 
coded as ‘No reported PCOS’ (participants who did not report a diagnosis of PCOS at either 




Participants were asked how many serves of vegetables they usually eat each day. Scores on 
a 7-point scale (1=none, 2=less than 1 serve, 3=1 serve, 4=2 serves, 5=3 serves, 6=4 serves, 
7=5 serves or more) were categorised into either “meets” (4 or more serves of 
  Impact of a PCOS diagnosis on behaviour 
 8 
vegetables/day) or “does not meet” recommendations based on Australian dietary 
guidelines (NHMRC, 2013). Vegetable intake has been found to be an important indicator of 
diet quality (Aljadani et al., 2013; Ledoux et al., 2011). A transition variable was derived to 
identify participants who at T2 either started meeting recommendations, did not change 
their intake, or stopped meeting recommendations.  
 
Physical activity  
Physical activity was measured using the validated and widely used self-report Active 
Australia Survey (Brown et al., 2008; Fjeldsoe et al., 2013). Participants were asked to report 
their frequency and duration of four activities in the last week: walking briskly, moderate 
leisure activity (e.g. social tennis, recreational swimming), vigorous leisure activity (e.g. 
vigorous cycling, running) and vigorous household or garden chores (Brown et al., 2012). 
Minutes spent in each activity was multiplied by a metabolic equivalent score to reflect the 
average intensity of the activity (x3.33 for walking and moderate activities, and x6.66 for 
vigorous activities). One metabolic equivalent is defined as energy expenditure at rest 
(Australian Institute of Health and Welfare, 2004). Scores were then summed to estimate 
total metabolic minutes/week. Outliers were truncated at 5600 metabolic minutes/week 
(equating to 28 hours/week of moderate intensity activity). A change score was calculated 
for each participant by subtracting the summed score at T1 from the summed score at T2.  
 
Contraceptive use  
Participants were asked about contraceptive use the last time they had vaginal sex and 
given a list of six options to choose from: ‘the pill’, ‘condoms’, ‘Implanon’, ‘Mirena’, ‘other 
contraceptive’ or ‘none’. Responses at each time point were categorised into either using 
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contraception (including ‘other contraceptive’) or not using contraception. A change 
variable was then generated to identify those who started using contraception, did not 
change their contraceptive behaviour, or stopped using contraception at T2.  
 
Secondary outcomes 
Psychosocial distress  
Psychological distress was assessed using the Kessler 10 (K10) scale. The scale consists of 10 
items on a 5-point scale (1=‘None of the time’ to 5=‘All of the time’), measuring symptoms 
of distress in the past 4 weeks. The items are summed to give a total score, which ranges 
from 10-50, with higher scores indicating greater psychological distress (Kessler et al., 2003). 
A change score was calculated by subtracting total K10 at T1 from total K10 at T2.  
 
BMI  
Body mass index (BMI) (kg/m2) was calculated from self-reported body weight and height.   
 
Demographics, possible related factors and covariates  
Sociodemographic information was collected in each survey, including age (in years), 
highest level of education (less than year 12, year 12, certificate or diploma, or university 
degree), relationship status (single, in a relationship, or separated/divorced), ability to 
manage on income (easy/ not bad, difficult some of the time, difficult all of the time/ 
impossible), ever had a live birth (yes or no), and location (urban, rural or overseas). 
Participants were also asked whether they had ever been diagnosed with or treated for a 
chronic health condition associated with PCOS (type 2 diabetes, hypertension and heart 
disease) or endometriosis.  




Differences in sociodemographic variables at T1 between women newly diagnosed with 
PCOS at T2 and women without PCOS were assessed using independent t-tests for 
continuous variables and chi-square tests for categorical variables. Multinomial logistic 
regression was used to assess change in vegetable intake (increase, do not change, or 
decrease intake) by PCOS status. Logistic regression was used to assess change in 
contraceptive use (stop using contraception or continue using contraception) by PCOS 
status for those using contraception at T1 and not currently pregnant at T2. Multivariable 
linear regression was used to analyse change in continuous outcomes: physical activity, 
psychological distress (K10) and BMI. All analyses controlled for baseline values of the 
outcome of interest. Potential confounding variables measured at T1 were added to the 
models as covariates in adjusted analyses. Covariates were selected based on their known 
or potential association with PCOS, prognostic importance for the outcome of interest, or 
because there were statistically significant differences between the groups on this variable 
at baseline. Stata/IC version 15 was used for all statistical analyses. P values <0.05 were 
considered statistically significant.  
 
Results 
PCOS status  
Of the 7,170 women included in the analysis, 222 (3%) reported a diagnosis of PCOS at T2 
but not at T1 (“New PCOS”), leaving 6948 (97%) women not reporting a diagnosis of PCOS 
for the control group (“No reported PCOS”).  
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Baseline characteristics  
Characteristics of women at T1 by PCOS status at T2 are presented in Table I. On average, 
women newly diagnosed with PCOS at T2 had a higher BMI, were less educated and had 
more difficulty managing on their income at T1 than women not reporting a diagnosis of 
PCOS. Women in the New PCOS group reported higher levels of psychological distress at T1 
and were also more likely to have a diagnosis of a chronic condition associated with PCOS 
(type 2 diabetes, hypertension and heart disease) and to have endometriosis. The groups 
did not differ in age, relationship status, area of residence or parity. 
 
Descriptive statistics  
Summary statistics for primary and secondary outcome variables at T1 and T2 are provided 
in Table II. At T2, around 1 in 5 women from both groups met Australian guidelines for 
vegetable intake per day. The majority of individuals in both groups exceeded 
recommended guidelines for physical activity, although there was large variability (Brown et 
al., 2012). In the new PCOS group, 27% reported moderate levels of psychological distress, 
31% high distress and 23% very high distress, according to K10 scale classifications (Andrews 
& Slade, 2001). In the no reported PCOS group, 32% reported experiencing moderate, 26% 
high and 15% very high distress. Both groups included a greater proportion of individuals 
indicating higher psychological distress than age-matched population data (moderate: 23%, 
high: 15%, very high: 5%; Australian Bureau of Statistics, 2015). On average, women newly 
diagnosed with PCOS were in the overweight BMI range, whilst women not reporting a 
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Main outcomes 
Change in vegetable intake 
In unadjusted analyses, women newly diagnosed with PCOS were no more likely to have 
increased their vegetable intake (relative to no change) than women not reporting a 
diagnosis of PCOS (see Table II for proportions & Table III for statistical output). Similarly, 
women newly diagnosed with PCOS were no more likely to have decreased their vegetable 
intake (relative to no change) than women without PCOS. When controlling for 
demographics, chronic conditions, endometriosis, BMI and psychological distress at T1, the 
results remained statistically non-significant (Table S1, S2, S3). 
 
Change in physical activity  
In unadjusted analyses, there was no statistical evidence of a difference in the amount of 
change in physical activity from T1 to T2 between women newly diagnosed with PCOS and 
women not reporting a PCOS diagnosis. Adjustments for demographics, chronic conditions, 
endometriosis, BMI and psychological distress at T1 did not substantially change the results 
(Table III).  
 
Change in contraceptive use  
Of the women using contraception at T1 and not currently pregnant at T2, 14% of women in 
the New PCOS group had stopped using contraception compared to 4% of women without a 
PCOS diagnosis, indicating an absolute risk difference of 9%. In unadjusted analyses, women 
with a new PCOS diagnosis were 3.4 times more likely to stop using contraception than 
women without a diagnosis (Table III). After adjusting for demographics, chronic conditions, 
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endometriosis, BMI and psychological distress at T1, women with a new diagnosis were 3.0 
times more likely to stop using contraception than women without a diagnosis. 
 
Secondary outcomes 
No significant differences between groups were found in terms of changes in BMI or 
psychological distress. Adjustments for demographics, chronic conditions, endometriosis, 
BMI and psychological distress at T1 did not substantially change the results (Table III).  
 
Analysis by BMI subgroup 
Post-hoc investigations of changes in vegetable intake and physical activity with regards to 
different BMI classifications showed no effect modification of PCOS status with BMI 
subgroup, suggesting that the differences between new PCOS and no reported PCOS groups 
did not vary as a function of BMI subgroup. 
 
Discussion 
In this study, using two waves of survey data from a large community sample collected 12 
months apart, young women newly diagnosed with PCOS were no more likely to change 
their vegetable intake or physical activity than women who did not report a diagnosis of 
PCOS. Regarding contraceptive use however, women newly diagnosed with PCOS were 
more likely to stop using contraception within a year of diagnosis than women without a 
PCOS diagnosis over the same 12-month period. These findings suggest that a diagnosis of 
PCOS may not produce short-term benefits by way of improving health behaviour to reduce 
risk of metabolic consequences and could possibly have a negative impact in terms of 
reducing contraceptive use for women if they are not actively trying to conceive.  
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Hormonal contraceptives, such as the combined oral contraceptive pill, are recommended 
first line treatment for women with symptoms such as irregular periods, acne and hirsutism 
(Legro et al., 2013; Teede et al., 2018). Despite this, the current study found that women 
reporting a new diagnosis of PCOS were more likely to have stopped using any method of 
contraception, supporting previous findings in various age cohorts where women with PCOS 
were less likely to be using contraception than women without PCOS (Joham et al., 2014; 
Rowlands et al., 2016). Possible reasons for this could be that doctors may counsel women 
about their risk of subfertility and the importance of family planning. As a result, women 
with PCOS may be more likely to be trying to become pregnant earlier than their peers. 
Indeed, a previous cross-sectional study of women aged 28-33 years (Joham et al., 2014) 
found that women with PCOS were more likely to be trying to conceive than women 
without PCOS. However, contraceptive use was lower for women with PCOS not planning to 
conceive as well (Joham et al., 2014). The average age of women in the current study is 
much younger (22.5 years at Time 2) than the average age (28.7 years) of first-time mothers 
in Australia in 2014 (AIHW, 2016), suggesting these women may be altering their life plans 
and trying to conceive younger than women without PCOS. Additionally, many women with 
PCOS experience fear of infertility and believe their fertility to be reduced (Holton et al., 
2018; Varanasi et al., 2018; Weiss & Bulmer, 2011), despite evidence showing women with 
PCOS have similar numbers of children to women without PCOS (Holton et al., 2018; Joham 
et al., 2014; Varanasi et al., 2018). A harmful consequence of this may be that they believe 
pregnancy to be unlikely and therefore they take risks with not using contraception (Jones 
et al., 2011; Copp et al., 2019). This suggests inadequate education about fertility potential, 
as whilst some may have trouble ovulating and need reproductive assistance, women with 
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PCOS can conceive spontaneously and therefore need to use contraception to avoid 
pregnancy if it is not wanted (Holton et al., 2018). The number of women currently trying to 
conceive was not assessed in the ALSWH study however, so exact numbers are unknown. 
Alternatively, some of these women may have been diagnosed with PCOS after stopping use 
of hormonal contraception, as stopping hormonal contraception can reveal PCOS 
symptoms. More systematic ways of measuring the consequences of being diagnosed with 
PCOS are needed.  
 
Although it is speculated that patients may view their diagnosis as a “wake-up call” for 
adopting a healthier lifestyle (Dontje et al., 2016), women in the current study did not 
become more physically active or improve their vegetable intake after being diagnosed with 
PCOS. Only 22% of women newly diagnosed with PCOS were meeting Australian dietary 
guidelines for vegetable intake (similar to those without PCOS [21%]) at T2. These findings 
differ to the results of a cross-sectional study of women aged 31-36 years, which found that 
women with PCOS were more likely to be following both healthy (low glycaemic-index diet, 
reducing fat or sugar intake, or reducing meal or snack size) and maladaptive weight 
management practices (fasting, smoking, use of laxatives) than women without PCOS 
(Moran et al., 2017). However, this study is cross-sectional (outcomes measured on a single 
occasion) so it is uncertain whether these differences existed prior to, or are due to the 
diagnosis, limiting comparisons with the current study. Though the majority of participants 
in the current study were already meeting physical activity recommendations, these results 
are consistent with a growing body of longitudinal evidence showing no change in physical 
activity after receiving personalised risk information or a chronic disease diagnosis (Dontje 
et al., 2016; French et al., 2017; Hollands et al., 2016). Furthermore, the results of the 
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current study support previous findings that women with PCOS experience greater 
psychological distress than women without PCOS (Dokras et al., 2011; Dokras et al., 2012), 
which is evident before and after being diagnosed with PCOS (Rowlands et al., 2016) and 
remains even after adjustment for other demographic and health variables that may 
contribute to psychological distress. Further investigation of the cause of this increased 
distress is warranted.    
 
Strengths and limitations  
To date, this is the first population-based cohort study to focus specifically on how young 
women’s health behaviour changes after receiving a diagnosis of PCOS, using a prospective 
longitudinal design. The study used a large, community sample of young women from a 
national longitudinal women’s health survey, which has previously been shown to be mostly 
representative of the Australian population, increasing generalisability (Loxton et al., 2017). 
Moreover, the nature of the data enabled comparison of those reporting a new diagnosis of 
PCOS with a large, age-matched control group over the same time period. Given that it 
would be unethical to randomly assign participants to receive a diagnosis of PCOS, the 
prospective design is the best available way of investigating potential causal relations 
between the diagnosis and outcomes. A limitation of the current study is that all data are 
self-reported, including PCOS diagnosis, however self-reported PCOS diagnosis has 
previously been validated in another ALSWH cohort (Teede et al., 2013). The number of 
women reporting a new diagnosis of PCOS was also relatively small; yet is consistent with 
analysis of previous waves of the ALSWH (Rowlands et al., 2016). Additionally, the exact 
timing of the diagnosis was not ascertained, so the duration of time between receiving the 
diagnosis and completing the survey remains unknown. However, the current study 
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assessed changes over a fixed 12-month period during which any changes as a result of the 
diagnosis are expected to occur. Nevertheless, there may be other delayed or longer-term 
effects of receiving the diagnosis (or indeed temporary behaviour changes that reverted 
within the study period) that have not been captured in the current data. Furthermore, the 
assessment of diet quality was limited to vegetable intake, which may not have captured 
other improvements in diet (e.g. reduced snacking or changed carbohydrate intake), 
although previous research has identified vegetable intake as a key indicator of diet quality 
(Aljadani et al., 2013; Ledoux et al., 2011).   
 
Implications and conclusions   
These results illustrate that a diagnosis of PCOS may not lead women to adopt more 
healthy, active lifestyles in the months following diagnosis. This could be due to lack of 
advice and support from healthcare providers (Gibson-Helm et al., 2017), or could be a 
result of personal barriers and factors. Psychological theories of cognitive bias, such as 
genetic essentialism, suggest that disease labels can evoke genetic explanations, leading 
people to believe they have little control over their symptoms such as weight, causing 
reduced belief in the effectiveness of lifestyle change (Dar-Nimrod & Heine, 2011). These 
results reflect the challenges with engagement and compliance, underscoring the clinical 
challenges in PCOS and other chronic diseases. These findings, together with previous 
literature (Lin et al., 2018), illustrate a need for more tailored support and engagement in 
behavioural strategies as outlined in new international guidelines (Teede et al., 2018) to 
increase healthy behaviour in newly diagnosed women and maximise the benefits of 
knowing this diagnosis. Effective discussions around a new diagnosis of PCOS should also 
address women’s beliefs and perceived locus of control to increase their self-efficacy and 
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also dispel myths (e.g. the non-evidence-based belief that PCOS causes weight gain or 
prevents weight loss; Brower et al., 2018; Kataoka et al., 2017). Some of these 
misperceptions are addressed in the new international guidelines, for example, clarifying 
that lifestyle interventions are equally effective in women with PCOS compared to women 
without PCOS and that most women with PCOS achieve their desired family size (Teede et 
al., 2018). More research is needed to further understand the impact of a PCOS diagnosis on 
health behaviour in larger samples of newly diagnosed patients employing longitudinal 
designs. The observed reduction in contraceptive use requires careful consideration, as it 
could increase the risk of unplanned pregnancies and also prevent women from receiving 
any benefit from treatment of hormonal PCOS symptoms via hormonal contraceptives. 
Unintended pregnancies can have an enormous impact on the economic, psychological, 
social and physical aspects of women’s lives (Gipson et al., 2008), so it is vital that doctors 
reinforce the importance of using contraception for women with PCOS who are not trying to 
conceive.  
 
In conclusion, these findings suggest that the diagnosis provides limited benefit by way of 
improving health behaviour or psychological distress but could have a negative impact in 
terms of reducing contraceptive use for women not actively trying to conceive. Careful 
consideration of the benefits and harms of the PCOS diagnosis is therefore a priority to 
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